Platelet bioreactor-on-a-chip

Blood

Volumn 124, Issue 12, 2014, Pages 1857-1867

  Thon, Jonathan N ^a,b,c   Mazutis, Linas ^c,d,e   Wu, Stephen ^a   Sylman, Joanna L ^f   Ehrlicher, Allen ^d,g   Machlus, Kellie R ^a,b   Feng, Qiang ^h   Lu, Shijiang ^h   Lanza, Robert ^h   Neeves, Keith B ^f,i   Weitz, David A ^d   Italiano, Joseph E ^a,b,c,j  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Platelet BioGenesis   (United States)

^d HARVARD UNIVERSITY   (United States)

^e VILNIUS UNIVERSITY   (Lithuania)

^f Department of Geology and Geological Engineering   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h Medical and Scientific Development Advanced Cell Technology   (United States)

ⁱ Children's Hospital Colorado   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOREACTOR; BIOREACTOR DESIGN; BLOOD STORAGE; BLOOD VESSEL PARAMETERS; BONE MARROW; CELL STRUCTURE; ENDOTHELIUM CELL; EX VIVO STUDY; EXTRACELLULAR MATRIX; HEMODYNAMICS; HUMAN; HUMAN CELL; IN VITRO STUDY; LAB ON A CHIP; MEGAKARYOCYTE; MICROENVIRONMENT; MICROFLUIDIC ANALYSIS; MICROFLUIDICS; MICROSCOPY; MOUSE; NONHUMAN; PHYSICAL PARAMETERS; PLATELET BIOREACTOR; PLURIPOTENT STEM CELL; RIGIDITY; RISK ASSESSMENT; SHEAR STRESS; THROMBOCYTE; THROMBOCYTE RELEASE REACTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPOIESIS; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; EQUIPMENT DESIGN; PHYSIOLOGY;

BIOMIMETIC MATERIAL;

ANIMALS; BIOMIMETIC MATERIALS; BIOREACTORS; BLOOD PLATELETS; EQUIPMENT DESIGN; HUMANS; MEGAKARYOCYTES; MICE; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; PLATELET TRANSFUSION; THROMBOPOIESIS;

EID: 84907222943     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-05-574913     Document Type: Article

References (54)

1. Linden MD, Jackson DE. Platelets: pleiotropic roles in atherogenesis and atherothrombosis. Int J Biochem Cell Biol. 2010;42(11):1762-1766.
2. Battinelli EM, Markens BA, Italiano JE Jr. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood. 2011;118(5): 1359-1369.
3. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011;11(4):264-274.
4. Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7(6):911-918.
5. Sullivan MT, Cotten R, Read EJ, Wallace EL. Blood collection and transfusion in the United States in 2001. Transfusion. 2007;47(3):385-394.
6. Cobain TJ, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfus Med. 2007;17(1):1-15.
7. Thon JN, Schubert P, Devine DV. Platelet storage lesion: a new understanding from a proteomic perspective. Transfus Med Rev. 2008;22(4): 268-279.
8. Ohto H, Nollet KE. Overview on platelet preservation: better controls over storage lesion. Transfus Apheresis Sci. 2011;44(3):321-325.
9. Whitaker BI, Schlump K, Schulman J, Green J. Report of the US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. Washington, DC: US Department of Health and Human Services, Office of the Assistant Secretary for Health; 2011.
10. Coller BS. Historical perspective and future directions in platelet research. J Thromb Haemost. 2011;9(Suppl 1):374-395.
11. Zhang L, Orban M, Lorenz M, et al. A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. J Exp Med. 2012;209(12): 2165-2181.
12. Leven RM. Megakaryocyte motility and platelet formation. Scanning Microsc. 1987;1(4): 1701-1709.
13. Leven RM, Yee MK. Megakaryocyte morphogenesis stimulated in vitro by whole and partially fractionated thrombocytopenic plasma: a model system for the study of platelet formation. Blood. 1987;69(4):1046-1052.
14. Tablin F, Castro M, Leven RM. Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation. J Cell Sci. 1990; 97(Pt 1):59-70.
15. Junt T, Schulze H, Chen Z, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science. 2007;317(5845):1767-1770.
16. Kaufman RM, Airo R, Pollack S, Crosby WH. Circulating megakaryocytes and platelet release in the lung. Blood. 1965;26(6):720-731.
17. Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood. 1995;85(2):402-413.
18. Lambert MP, Sullivan SK, Fuentes R, French DL, Poncz M. Challenges and promises for the development of donor-independent platelet transfusions. Blood. 2013;121(17):3319-3324.
19. Larson MK, Watson SP. A product of their environment: do megakaryocytes rely on extracellular cues for proplatelet formation? Platelets. 2006;17(7):435-440.
20. Takahashi R, Sekine N, Nakatake T. Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation. Blood. 1999;93(6): 1951-1958.
21. Shin JW, Swift J, Spinler KR, Discher DE. Myosin- II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes. Proc Natl Acad Sci USA. 2011;108(28):11458-11463.
22. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004; 10(1):64-71.
23. Fujimoto TT, Kohata S, Suzuki H, Miyazaki H, Fujimura K. Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood. 2003;102(12):4044-4051.
24. Dunois-Lardé C, Capron C, Fichelson S, Bauer T, Cramer-Bordé E, Baruch D. Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood. 2009;114(9): 1875-1883.
25. Thon JN, Montalvo A, Patel-Hett S, et al. Cytoskeletal mechanics of proplatelet maturation and platelet release. J Cell Biol. 2010;191(4): 861-874.
26. Thon JN, Devine MT, Jurak Begonja A, Tibbitts J, Italiano JE Jr. High-content live-cell imaging assay used to establish mechanism of trastuzumab emtansine (T-DM1)-mediated inhibition of platelet production. Blood. 2012; 120(10):1975-1984.
27. El-Ali J, Sorger PK, Jensen KF. Cells on chips. Nature. 2006;442(7101):403-411.
28. Mazutis L, Gilbert J, Ung WL, Weitz DA, Griffiths AD, Heyman JA. Single-cell analysis and sorting using droplet-based microfluidics. Nat Protoc. 2013;8(5):870-891.
29. Prabhakarpandian B, Shen MC, Pant K, Kiani MF. Microfluidic devices for modeling cell-cell and particle-cell interactions in the microvasculature. Microvasc Res. 2011;82(3):210-220.
30. Kessel RG, Kardon RH. Circulating blood, blood vessels, and bone marrow. In: Johnson D, ed. Tissues and organs: a text-atlas of scanning electron microscopy. San Francisco: W.H. Freeman and Company; 1979:35-50.
31. Behnke O. An electron microscope study of the rat megacaryocyte. II. Some aspects of platelet release and microtubules. J Ultrastruct Res. 1969; 26(1):111-129.
32. Becker RP, De Bruyn PP. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. Am J Anat. 1976;145(2):183-205.
33. Winer JP, Janmey PA, McCormick ME, Funaki M. Bone marrow-derived human mesenchymal stem cells become quiescent on soft substrates but remain responsive to chemical or mechanical stimuli. Tissue Eng Part A. 2009; 15(1):147-154.
34. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials. 1999;20(1):45-53.
35. Tangelder GJ, Slaaf DW, Arts T, Reneman RS. Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol. 1988;254(6 Pt 2):H1059-H1064.
36. Looney MR, Thornton EE, Sen D, Lamm WJ, Glenny RW, Krummel MF. Stabilized imaging of immune surveillance in the mouse lung. Nat Methods. 2011;8(1):91-96.
37. Mazo IB, von Andrian UH. Adhesion and homing of blood-borne cells in bone marrow microvessels. J Leukoc Biol. 1999;66(1):25-32.
38. Neeves KB, Onasoga AA, Wufsus AR. The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury. CurrOpin Hematol. 2013;20(5):417-423.
39. Zucker-Franklin D, Philipp CS. Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept. Am J Pathol. 2000; 157(1):69-74.
40. Thon JN, Macleod H, Begonja AJ, et al. Microtubule and cortical forces determine platelet size during vascular platelet production. Nat Commun. 2012;3:852.
41. Patel SR, Hartwig JH, Italiano JE Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest. 2005;115(12): 3348-3354.
42. Fuentes R, Wang Y, Hirsch J, et al. Infusion of mature megakaryocytes into mice yields functional platelets. J Clin Invest. 2010;120(11): 3917-3922.
43. Lu SJ, Li F, Yin H, et al. Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res. 2011;21(3):530-545.
44. Takayama N, Nishikii H, Usui J, et al. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood. 2008;111(11):5298-5306.
45. Thon JN, Italiano JE. Platelets: production, morphology and ultrastructure. Handb Exp Pharmacol. 2012;210:3-22.
46. Gaur M, Kamata T, Wang S, Moran B, Shattil SJ, Leavitt AD. Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost. 2006;4(2): 436-442.
47. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-872.
48. Nakamura S, Takayama N, Hirata S, et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell. 2014;14(4):535-548.
49. Ahmed RP, Ashraf M, Buccini S, Shujia J, Haider HK. Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction. Regen Med. 2011; 6(2):171-178.
50. Nakagawa Y, Nakamura S, Nakajima M, et al. Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. Exp Hematol. 2013; 41(8):742-748.
51. Panuganti S, Papoutsakis ET, Miller WM. Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential. Cytotherapy. 2010; 12(6):767-782.
52. Lasky LC, Sullenbarger B. Manipulation of oxygenation and flow-induced shear stress can increase the in vitro yield of platelets from cord blood. Tissue Eng Part C Methods. 2011;17(11): 1081-1088.
53. Masuda S, Li M, Izpisua Belmonte JC. In vitro generation of platelets through direct conversion: first report in My Knowledge (iMK). Cell Res. 2013;23(2):176-178.
54. Pineault N, Boucher JF, Cayer MP, et al. Characterization of the effects and potential mechanisms leading to increased megakaryocytic differentiation under mild hyperthermia. Stem Cells Dev. 2008;17(3):483-493.